First Commonwealth Financial Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$564K Hold
1,135
0.08% 185
2026
Q1
$507K Buy
1,135
+1
+0.1% +$466 0.08% 178
2025
Q4
$514K Sell
1,134
-1
-0.1% -$431 0.08% 173
2025
Q3
$444K Sell
1,135
-67
-6% -$28K 0.07% 186
2025
Q2
$535K Hold
1,202
0.12% 152
2025
Q1
$583K Buy
1,202
+677
+129% +$315K 0.14% 142
2024
Q4
$211K Buy
+525
New +$243K 0.05% 208

Other funds holding VRTX

First Commonwealth Financial Corp's VRTX Position: Q2 2026 in Review

First Commonwealth Financial Corp held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,135 shares worth $564K. The position accounts for 0.08% of the portfolio, ranked #185.

First Commonwealth Financial Corp first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $583K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • First Commonwealth Financial Corp held 1,135 shares of Vertex Pharmaceuticals worth $564K as of Q2 2026.
  • First Commonwealth Financial Corp left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.08% of First Commonwealth Financial Corp's portfolio in Q2 2026, its #185 holding.
  • First Commonwealth Financial Corp first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • First Commonwealth Financial Corp's Vertex Pharmaceuticals position peaked at $583K in Q1 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on First Commonwealth Financial Corp's 13F filing for Q2 2026, filed 12 Aug 2026.